AMLX Amylyx Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1658551 · EDGAR
- Bought, last 12 months
- $152.2K 2 purchases by 1 insiders
- Sold, last 12 months
- $10.62M 27 sales by 5 insiders
- Filings on record
- 182 since 2022-01-10, latest 2026-09-14 16:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| Mazzariello Gina | CLO | — | $1.18M |
| FRATES JAMES M | CFO | — | $708.4K |
| Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| Firestone Karen | Dir | $152.2K | — |
| MILNE GEORGE M JR | Dir | — | — |
Transactions 176
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-11 | 2024-01-09 | AMLX | Klee Justin B. | Co-CEO, Dir | S - Sale | $16.33 | -5,841 | 2.84M | -0.2% | -$95.4K | |
| D | 2023-12-29 | 2023-12-27 | AMLX | Olinger Margaret | Chief Commercial Off | M - OptEx | $0.37 | +25.0K | 276.1K | +10% | +$9,250 |
| 2023-12-19 | 2023-12-15 | AMLX | Firestone Karen | Dir | P - Purchase | $14.97 | +4,000 | 5,000 | +400% | +$59.9K | |
| D | 2023-11-29 | 2023-11-27 | AMLX | Bedrosian Camille L | Chief Medical Off | A - Grant | $0.00 | +58.3K | 58.3K | New | $0 |
| D | 2023-11-20 | 2023-11-16 | AMLX | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $1.57 | +63.7K | 2.91M | +2% | +$100.0K |
| I | 2023-11-02 | 2023-10-31 | AMLX | FRATES JAMES M | CFO | G - Gift | $0.00 | +11.1K | 11.1K | New | $0 |
| D | 2023-08-24 | 2023-08-23 | AMLX | FRATES JAMES M | CFO | M - OptEx | $6.88 | +18.2K | 106.3K | +21% | +$125.0K |
| 2023-08-17 | 2023-08-15 | AMLX | Morningside Venture Investments Ltd | 10% | G - Gift | $0.00 | -2.00M | 5.00M | -29% | $0 | |
| T | 2023-08-17 | 2023-08-15 | AMLX | Mazzariello Gina | CLO | S - Sale | $20.88 | -6,164 | 49.1K | -11% | -$128.7K |
| D | 2023-07-14 | 2023-07-12 | AMLX | Olinger Margaret | Chief Commercial Off | M - OptEx | $0.37 | +20.0K | 251.1K | +9% | +$7,400 |
| 2023-05-24 | 2023-05-22 | AMLX | Olinger Margaret | Chief Commercial Off | G - Gift | $0.00 | -1,580 | 231.1K | -0.7% | $0 | |
| 2023-05-19 | 2023-05-17 | AMLX | Mazzariello Gina | CLO | G - Gift | $0.00 | -500 | 55.2K | -0.9% | $0 | |
| D | 2023-05-18 | 2023-05-16 | AMLX | FRATES JAMES M | CFO | M - OptEx | $6.88 | +32.5K | 88.2K | +58% | +$223.6K |
| DM | 2023-05-18 | 2023-05-16 | AMLX | FRATES JAMES M | CFO | S - Sale+OE | $26.94 | -32.5K | 55.7K | -37% | -$875.6K |
| DMT | 2023-05-17 | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Off | M - OptEx | $5.68 | +12.0K | 220.4K | +6% | +$68.0K |
| DT | 2023-05-17 | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $29.03 | -12.0K | 208.4K | -5% | -$347.3K |
| DAI | 2023-04-26 | 2022-01-06 | AMLX | FRATES JAMES M | CFO | C - Cnv Deriv | $0.00 | +19.5K | 19.5K | New | $0 |
| DM | 2023-04-19 | 2023-04-17 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $30.53 | -49.6K | 208.7K | -19% | -$1.51M |
| DM | 2023-04-19 | 2023-04-17 | AMLX | Yeramian Patrick D | Chief Medical Off | M - OptEx | $0.9895 | +49.6K | 258.0K | +24% | +$49.1K |
| 2023-03-31 | 2023-03-29 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $30.45 | -29.0K | 7.00M | -0.4% | -$884.5K | |
| M | 2023-03-29 | 2023-03-27+ | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $30.42 | -161.0K | 7.03M | -2% | -$4.90M |
| DA | 2023-03-24 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | A - Grant | $0.00 | +21.7K | 55.7K | +64% | $0 |
| DMA | 2023-03-24 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | S - Sale+OE | $31.89 | -32.5K | 35.7K | -48% | -$1.04M |
| DA | 2023-03-24 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | M - OptEx | $6.88 | +32.5K | 66.5K | +96% | +$223.6K |
| DA | 2023-03-24 | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +9,167 | 208.4K | +5% | $0 |
| DMA | 2023-03-24 | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $31.88 | -54.6K | 201.7K | -21% | -$1.74M |
| DMA | 2023-03-24 | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Off | M - OptEx | $2.57 | +49.6K | 237.1K | +26% | +$127.3K |
| M | 2023-03-23 | 2023-03-21 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $31.91 | -63.4K | 7.22M | -0.9% | -$2.02M |
| DM | 2023-03-20 | 2023-03-16 | AMLX | Klee Justin B. | Co-CEO, Dir | S - Sale | $31.86 | -100.0K | 2.79M | -3% | -$3.19M |
| D | 2023-03-20 | 2023-03-16 | AMLX | Klee Justin B. | Co-CEO, Dir | A - Grant | $0.00 | +50.0K | 2.84M | +2% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | S - Sale | $31.89 | -32.5K | 3,213 | -91% | -$1.04M |
| D | 2023-03-20 | 2023-03-16 | AMLX | FRATES JAMES M | CFO | A - Grant | $0.00 | +21.7K | 23.2K | +1,436% | $0 |
| D | 2023-03-20 | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +9,167 | 158.8K | +6% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale | $31.88 | -54.6K | 149.7K | -27% | -$1.74M |
| D | 2023-03-20 | 2023-03-16 | AMLX | Firestone Karen | Dir | P - Purchase | $31.99 | +1,000 | 1,000 | New | +$32.0K |
| D | 2023-03-20 | 2023-03-16 | AMLX | Olinger Margaret | Chief Commercial Off | A - Grant | $0.00 | +18.3K | 232.7K | +9% | $0 |
| M | 2023-03-20 | 2023-03-16 | AMLX | MILNE GEORGE M JR | Dir | S - Sale | $31.89 | -35.0K | 862.0K | -4% | -$1.12M |
| D | 2023-03-20 | 2023-03-16 | AMLX | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +50.0K | 2.84M | +2% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AMLX | Cohen Joshua B | Co-CEO, Dir | S - Sale | $31.86 | -100.0K | 2.79M | -3% | -$3.19M |
| D | 2023-03-20 | 2023-03-16 | AMLX | Mazzariello Gina | CLO | A - Grant | $0.00 | +18.3K | 55.7K | +49% | $0 |
| 2023-03-17 | 2023-03-16 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $32.55 | -9,122 | 7.25M | -0.1% | -$296.9K | |
| M | 2023-03-16 | 2023-03-14+ | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $33.68 | -220.7K | 7.41M | -3% | -$7.43M |
| 2023-03-06 | 2023-03-02 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $33.75 | -50.0K | 7.48M | -0.7% | -$1.69M | |
| 2023-02-28 | 2023-02-24 | AMLX | Mazzariello Gina | CLO | S - Sale | $34.49 | -3,586 | 37.4K | -9% | -$123.7K | |
| M | 2023-02-28 | 2023-02-22 | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $34.73 | -50.0K | 7.53M | -0.7% | -$1.74M |
| M | 2023-02-24 | 2023-02-22+ | AMLX | Morningside Venture Investments Ltd | 10% | S - Sale | $35.78 | -100.0K | 7.64M | -1% | -$3.58M |
| M | 2023-01-10 | 2023-01-06 | AMLX | Olinger Margaret | Chief Commercial Off | S - Sale | $36.30 | +2,403 | 214.4K | +1% | +$87.2K |
| M | 2023-01-10 | 2023-01-06 | AMLX | Klee Justin B. | Co-CEO, Dir | S - Sale | $36.30 | +5,968 | 2.89M | +0.2% | +$216.6K |
| M | 2023-01-10 | 2023-01-06 | AMLX | FRATES JAMES M | CFO | S - Sale | $36.30 | +2,658 | 34.8K | +8% | +$96.5K |
| M | 2023-01-10 | 2023-01-06 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale | $36.30 | +2,034 | 204.9K | +1% | +$73.8K |
| M | 2023-01-10 | 2023-01-06 | AMLX | Cohen Joshua B | Co-CEO, Dir | S - Sale | $36.30 | +5,968 | 2.89M | +0.2% | +$216.6K |
| D | 2023-01-04 | 2022-12-30 | AMLX | FRATES JAMES M | CFO | M - OptEx | $6.88 | +5,000 | 36.7K | +16% | +$34.4K |
| MI | 2022-09-09 | 2022-09-08+ | AMLX | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% | S - Sale | $29.80 | -1.40M | 4.68M | -23% | -$41.72M |
| M | 2022-07-08 | 2022-07-06 | AMLX | ALS Invest 1 B.V. | 10% | S - Sale | $20.70 | -60.6K | 5.90M | -1% | -$1.25M |
| D | 2022-05-06 | 2022-05-05 | AMLX | Klee Justin B. | Co-CEO, Dir | M - OptEx | $0.37 | +334.5K | 2.90M | +13% | +$123.8K |
| D | 2022-05-06 | 2022-05-05 | AMLX | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $0.37 | +334.5K | 2.90M | +13% | +$123.8K |
| DM | 2022-05-05 | 2022-01-11 | AMLX | ALS Invest 1 B.V. | 10% | C - Cnv Deriv | — | +5.96M | 1.13M | New | — |
| DAI | 2022-03-17 | 2022-01-11 | AMLX | MVIL, LLC | 10% | C - Cnv Deriv | — | +10.42M | 10.42M | New | — |
| DAI | 2022-03-17 | 2022-01-11 | AMLX | MVIL, LLC | 10% | P - Purchase | $19.00 | +263.2K | 10.68M | +3% | +$5.00M |
| D | 2022-02-28 | 2022-02-22 | AMLX | Mazzariello Gina | CLO | A - Grant | $0.00 | +41.0K | 41.0K | New | $0 |
| D | 2022-01-25 | 2022-01-11 | AMLX | Morningside Venture Investments Ltd | 10% | P - Purchase | $19.00 | +263.2K | 10.68M | +3% | +$5.00M |
| D | 2022-01-25 | 2022-01-11 | AMLX | Morningside Venture Investments Ltd | 10% | C - Cnv Deriv | — | +10.42M | 10.42M | New | — |
| DI | 2022-01-13 | 2022-01-11 | AMLX | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% | P - Purchase | $19.00 | +2.30M | 2.30M | New | +$43.70M |
| DI | 2022-01-13 | 2022-01-11 | AMLX | Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% | C - Cnv Deriv | — | +4.87M | 4.87M | New | — |
| D | 2022-01-10 | 2022-01-06 | AMLX | Olinger Margaret | Chief Commercial Off | P - Purchase | $19.00 | +6,842 | 216.8K | +3% | +$130.0K |
| D | 2022-01-10 | 2022-01-06 | AMLX | Olinger Margaret | Chief Commercial Off | A - Grant | $0.00 | +28.3K | 209.9K | +16% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Yeramian Patrick D | Chief Medical Off | A - Grant | $0.00 | +28.3K | 206.3K | +16% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | FRATES JAMES M | CFO | A - Grant | $0.00 | +31.7K | 31.7K | New | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +75.0K | 2.56M | +3% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Cohen Joshua B | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +4,870 | 2.49M | +0.2% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Klee Justin B. | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +4,870 | 2.49M | +0.2% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Klee Justin B. | Co-CEO, Dir | A - Grant | $0.00 | +75.0K | 2.56M | +3% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | FONTEYNE PAUL R. | Dir | P - Purchase | $19.00 | +3,947 | 3,947 | New | +$75.0K |
| D | 2022-01-10 | 2022-01-06 | AMLX | MILNE GEORGE M JR | Dir | P - Purchase | $19.00 | +26.3K | 221.4K | +13% | +$500.0K |
| DMI | 2022-01-10 | 2022-01-06 | AMLX | Cheng Isaac | Dir | C - Cnv Deriv | — | +10.42M | 1.41M | New | — |
| D | 2022-01-10 | 2022-01-06 | AMLX | Cheng Isaac | Dir | P - Purchase | $19.00 | +6,578 | 6,578 | New | +$125.0K |
Purchase Sale Sale after option exercise All abbreviations